• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD94和NKG2-A C型凝集素通过共价组装形成针对I类HLA分子的自然杀伤细胞抑制性受体。

The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.

作者信息

Carretero M, Cantoni C, Bellón T, Bottino C, Biassoni R, Rodríguez A, Pérez-Villar J J, Moretta L, Moretta A, López-Botet M

机构信息

Servicio de Immunología, Universidad Autónoma de Madrid, Spain.

出版信息

Eur J Immunol. 1997 Feb;27(2):563-7. doi: 10.1002/eji.1830270230.

DOI:10.1002/eji.1830270230
PMID:9045931
Abstract

CD94, a type II membrane protein containing a C-type lectin domain, has been shown to be involved in natural killer (NK) cell-mediated recognition of different HLA allotypes. The inhibitory form of the CD94 receptor has recently been identified by the specific monoclonal antibody (mAb) Z199. Herein, we demonstrate that the inhibitory receptor is in fact a complex formed by the covalent association of CD94 with the NKG2-A molecule (Mr approximately 43 kDa), another member of the C-type lectin superfamily, and that Z199 mAb specifically recognize NKG2-A molecules. Although the NKG2-A-encoding cDNA has been known for several years, the corresponding protein and its possible function remained undefined. Moreover, we show that the NKG2-B protein, an alternatively spliced product of the NKG2-A gene, can also assemble with CD94. Remarkably, both NKG2-A and NKG2-B proteins contain cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIM). This may provide the molecular basis of the inhibitory function mediated by the CD94/NKG2-A receptor complexes.

摘要

CD94是一种含有C型凝集素结构域的II型膜蛋白,已被证明参与自然杀伤(NK)细胞介导的对不同HLA同种异型的识别。CD94受体的抑制形式最近已被特异性单克隆抗体(mAb)Z199鉴定出来。在此,我们证明抑制性受体实际上是由CD94与C型凝集素超家族的另一个成员NKG2-A分子(分子量约43 kDa)共价结合形成的复合物,并且Z199单克隆抗体特异性识别NKG2-A分子。尽管编码NKG2-A的cDNA已经为人所知数年,但相应的蛋白质及其可能的功能仍未明确。此外,我们表明NKG2-B蛋白是NKG2-A基因的可变剪接产物,也可以与CD94组装。值得注意的是,NKG2-A和NKG2-B蛋白都含有基于免疫受体酪氨酸的抑制基序(ITIM)。这可能为CD94/NKG2-A受体复合物介导的抑制功能提供分子基础。

相似文献

1
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.CD94和NKG2-A C型凝集素通过共价组装形成针对I类HLA分子的自然杀伤细胞抑制性受体。
Eur J Immunol. 1997 Feb;27(2):563-7. doi: 10.1002/eji.1830270230.
2
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.CD94/NKG2-A抑制性受体复合物参与自然杀伤细胞介导的对表达HLA-G1细胞的识别。
J Immunol. 1997 Jun 15;158(12):5736-43.
3
HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.HLA-E在滋养层细胞上表达,并与蜕膜自然杀伤细胞上的CD94/NKG2受体相互作用。
Eur J Immunol. 2000 Jun;30(6):1623-31. doi: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M.
4
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.白细胞介素-15诱导人胸腺早期前体细胞自然杀伤细胞成熟:CD94/NKG2-A作为唯一的HLA I类特异性抑制性受体的选择性表达。
Eur J Immunol. 1997 Jun;27(6):1374-80. doi: 10.1002/eji.1830270612.
5
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
6
Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.参与MHC I类识别的人类自然杀伤细胞受体是CD94和NKG2亚基的二硫键连接的异二聚体。
J Immunol. 1996 Dec 1;157(11):4741-5.
7
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.可溶性CD94/NKG2A和自然杀伤细胞对HLA-E具有特异性识别,而对经典的HLA I类分子则无此识别。
J Immunol. 1999 Jan 1;162(1):305-13.
8
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
9
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.
10
CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.CD94/NKG2是蜕膜和外周血自然杀伤细胞识别HLA-G所涉及的主要抑制性受体。
J Immunol. 1997 Aug 1;159(3):1072-5.

引用本文的文献

1
The next generation of immunotherapies for lung cancers.肺癌的下一代免疫疗法。
Nat Rev Clin Oncol. 2025 Jun 17. doi: 10.1038/s41571-025-01035-9.
2
Exploring the potential of CAR-NK cell therapy in the management of head and neck cancer (HNC): a narrative review.探索嵌合抗原受体自然杀伤(CAR-NK)细胞疗法在头颈部癌(HNC)治疗中的潜力:一项叙述性综述。
Ann Med Surg (Lond). 2025 Feb 7;87(4):2026-2034. doi: 10.1097/MS9.0000000000003002. eCollection 2025 Apr.
3
Next-generation immunotherapy: igniting new hope for lung cancer.下一代免疫疗法:点燃肺癌新希望。
Ther Adv Med Oncol. 2024 Dec 7;16:17588359241302021. doi: 10.1177/17588359241302021. eCollection 2024.
4
Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy.肿瘤微环境中的固有免疫细胞:癌症免疫治疗的新前沿。
iScience. 2024 Aug 17;27(9):110750. doi: 10.1016/j.isci.2024.110750. eCollection 2024 Sep 20.
5
Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.多基因多态性与 NKG2A 库有关,并影响淋巴细胞表型和功能。
Blood Adv. 2024 Oct 22;8(20):5382-5399. doi: 10.1182/bloodadvances.2024013508.
6
Cancer Cell Small Molecule Secretome Induces the Immune Checkpoint NKG2A and Dysfunction of Human CD8+ T Cells.癌细胞小分子分泌组诱导免疫检查点 NKG2A 和人 CD8+ T 细胞功能障碍。
Immunohorizons. 2024 Jun 1;8(6):464-477. doi: 10.4049/immunohorizons.2400046.
7
Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS-STING-IFNβ-HLA.间质基质细胞通过 cGAS-STING-IFNβ-HLA 的细胞间信号传递增加循环肿瘤细胞的自然杀伤抗性。
Adv Sci (Weinh). 2024 Jun;11(21):e2400888. doi: 10.1002/advs.202400888. Epub 2024 Apr 18.
8
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends.实体瘤的免疫检查点治疗:临床困境与未来趋势。
Signal Transduct Target Ther. 2023 Aug 28;8(1):320. doi: 10.1038/s41392-023-01522-4.
9
CD8 T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.CD8 T 细胞通过 NKG2D-NKG2DL 轴维持对 MHC-I 阴性肿瘤细胞的杀伤。
Nat Cancer. 2023 Sep;4(9):1258-1272. doi: 10.1038/s43018-023-00600-4. Epub 2023 Aug 3.
10
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.一种利用非侵入性细胞唾液采样和快速高灵敏度 ELISA 免疫分析法检测口腔癌生物标志物的新方法:一项在人类中的初步研究。
Front Immunol. 2023 Jul 6;14:1216107. doi: 10.3389/fimmu.2023.1216107. eCollection 2023.